Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients

Outcomes for patients with hematologic malignancy infected with COVID-19 have not been aggregated. The objective of this study was to perform a systematic review and meta-analysis to estimate the risk of death and other important outcomes for these patients. We searched PubMed and EMBASE up to 20 Au...

Descripción completa

Detalles Bibliográficos
Autores principales: Vijenthira, Abi, Gong, Inna Y., Fox, Thomas A., Booth, Stephen, Cook, Gordon, Fattizzo, Bruno, Martín-Moro, Fernando, Razanamahery, Jerome, Riches, John C., Zwicker, Jeff, Patell, Rushad, Vekemans, Marie Christiane, Scarfò, Lydia, Chatzikonstantinou, Thomas, Yildiz, Halil, Lattenist, Raphaël, Mantzaris, Ioannis, Wood, William A., Hicks, Lisa K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746126/
https://www.ncbi.nlm.nih.gov/pubmed/33113551
http://dx.doi.org/10.1182/blood.2020008824

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746126/
https://www.ncbi.nlm.nih.gov/pubmed/33113551
http://dx.doi.org/10.1182/blood.2020008824

Ejemplares similares